日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Efficacy of ATR Kinase Inhibitor Elimusertib Monotherapy or Combination in Tumors with DNA Damage Response Pathway and Other Genomic Alterations.

ATR激酶抑制剂Elimusertib单药或联合治疗对具有DNA损伤反应通路和其他基因组改变的肿瘤的疗效

Varadarajan Kaushik, Cruz Pico Christian X, Evans Kurt W, Raso Maria Gabriela, Rizvi Yasmeen Qamar, Zheng Xiaofeng, Chachad Dhruv, DiPeri Timothy P, Wang Bailiang, Scott Stephen M, Zhao Ming, Akcakanat Argun, Wengner Antje M, Yap Timothy A, Meric-Bernstam Funda

Natural Language Processing-Assisted Literature Retrieval and Analysis for Combination Therapy in Cancer

自然语言处理辅助的文献检索与分析在癌症联合治疗中的应用

Zeng, Jia; Cruz-Pico, Christian X; Saridogan, Turçin; Shufean, Md Abu; Kahle, Michael; Yang, Dong; Shaw, Kenna; Meric-Bernstam, Funda

Oxidative Phosphorylation Is a Metabolic Vulnerability in Chemotherapy-Resistant Triple-Negative Breast Cancer

氧化磷酸化是化疗耐药性三阴性乳腺癌的代谢弱点

Kurt W Evans, Erkan Yuca, Stephen S Scott, Ming Zhao, Natalia Paez Arango, Christian X Cruz Pico, Turcin Saridogan, Maryam Shariati, Caleb A Class, Christopher A Bristow, Christopher P Vellano, Xiaofeng Zheng, Ana Maria Gonzalez-Angulo, Xiaoping Su, Coya Tapia, Ken Chen, Argun Akcakanat, Bora Lim, D

Genomic, Transcriptomic, and Proteomic Profiling of Metastatic Breast Cancer

转移性乳腺癌的基因组、转录组和蛋白质组分析

Akcakanat, Argun; Zheng, Xiaofeng; Cruz Pico, Christian X; Kim, Tae-Beom; Chen, Ken; Korkut, Anil; Sahin, Aysegul; Holla, Vijaykumar; Tarco, Emily; Singh, Gopal; Damodaran, Senthil; Mills, Gordon B; Gonzalez-Angulo, Ana Maria; Meric-Bernstam, Funda

Combining Neratinib with CDK4/6, mTOR, and MEK Inhibitors in Models of HER2-positive Cancer

在 HER2 阳性癌症模型中将 Neratinib 与 CDK4/6、mTOR 和 MEK 抑制剂联合使用

Ming Zhao #, Stephen Scott #, Kurt W Evans, Erkan Yuca, Turcin Saridogan, Xiaofeng Zheng, Heping Wang, Anil Korkut, Christian X Cruz Pico, Mehmet Demirhan, Bryce Kirby, Scott Kopetz, Irmina Diala, Alshad S Lalani, Sarina Piha-Paul, Funda Meric-Bernstam